StockOtters
StockOttersSupply Chain Map
JW Pharmaceutical Corporation logo

JW Pharmaceutical Corporation

001060.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
540
Cost of Revenue
297
Gross Profit
243
Gross Margin
45.0%
Operating Income
62
Operating Margin
11.5%
Net Income
49
Net Margin
9.0%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
83
EBITDA Margin
15.3%

2023

12/31/2023

Revenue
561
Cost of Revenue
310
Gross Profit
252
Gross Margin
44.8%
Operating Income
75
Operating Margin
13.4%
Net Income
28
Net Margin
4.9%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
67
EBITDA Margin
11.9%

2022

12/31/2022

Revenue
513
Cost of Revenue
297
Gross Profit
216
Gross Margin
42.1%
Operating Income
47
Operating Margin
9.2%
Net Income
24
Net Margin
4.7%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
55
EBITDA Margin
10.7%

2021

12/31/2021

Revenue
455
Cost of Revenue
279
Gross Profit
176
Gross Margin
38.6%
Operating Income
23
Operating Margin
5.1%
Net Income
-1
Net Margin
-0.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
34
EBITDA Margin
7.4%

2020

12/31/2020

Revenue
411
Cost of Revenue
277
Gross Profit
133
Gross Margin
32.4%
Operating Income
-1
Operating Margin
-0.2%
Net Income
-11
Net Margin
-2.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
15
EBITDA Margin
3.5%